Literature DB >> 16288810

Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells.

Masanori Hangai1, Shikun He, Stephan Hoffmann, Jennifer I Lim, Stephen J Ryan, David R Hinton.   

Abstract

Inflammatory mediators have been proposed to play a critical role in the pathogenesis of choroidal neovascularization, a blinding complication of age-related macular degeneration. We evaluated the expression of TNF-alpha in human choroidal neovascular membranes and found that it colocalized with cells expressing VEGF, angiopoietin (Ang)-1 and Ang2. In cultured choroidal endothelial cells we found that TNF-alpha increased Ang2 mRNA (increased transcription) and protein levels prior to those of Ang1 and VEGF. The results raise the possibility that during neovascularization, TNF-alpha may modulate endothelial plasticity and survival by sequential inactivation of Tie2 followed by activation of Tie2 and VEGF receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288810     DOI: 10.1016/j.jneuroim.2005.09.018

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  22 in total

1.  Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.

Authors:  Kyoungmin Park; Ji Jin; Yang Hu; Kevin Zhou; Jian-xing Ma
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

3.  FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.

Authors:  Zhongjie Fu; Yan Gong; Raffael Liegl; Zhongxiao Wang; Chi-Hsiu Liu; Steven S Meng; Samuel B Burnim; Nicholas J Saba; Thomas W Fredrick; Peyton C Morss; Ann Hellstrom; Saswata Talukdar; Lois E H Smith
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.423

4.  Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization.

Authors:  Paola Bargagna-Mohan; Padma Priya Ravindranath; Royce Mohan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

5.  Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9.

Authors:  Jing Xu; Danhong Zhu; Shozo Sonoda; Shikun He; Christine Spee; Stephen J Ryan; David R Hinton
Journal:  Angiogenesis       Date:  2012-03-04       Impact factor: 9.596

Review 6.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

7.  Transcriptional regulation of bone morphogenetic protein 4 by tumor necrosis factor and its relationship with age-related macular degeneration.

Authors:  Jing Xu; Danhong Zhu; Shikun He; Christine Spee; Stephen J Ryan; David R Hinton
Journal:  FASEB J       Date:  2011-03-16       Impact factor: 5.191

8.  Normal aging involves modulation of specific inflammatory markers in the rat retina and choroid.

Authors:  Jena J Steinle; Sheena Sharma; Christopher P Smith; Lisa S McFayden-Ketchum
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

Review 9.  Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art.

Authors:  Claudia Fabiani; Antonio Vitale; Giuseppe Lopalco; Florenzo Iannone; Bruno Frediani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-09-30       Impact factor: 2.980

10.  Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infection/inflammation.

Authors:  Percy Pacora; Roberto Romero; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Offer Erez; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Chong Jai Kim; Nandor Gabor Than; Lami Yeo; Pooja Mittal; Sonia S Hassan
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.